loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of chemical intermediates, fine chemicals supplied/manufactured for 1076-22-8

    Client Virtual Booth
    Menu

    Bakul Group

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INTERMEDIATES

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Bakul Group (1)

    02 Bulat Pharmaceutical (1)

    03 Cangzhou Senary Chemical Science-tech Co., Ltd (1)

    04 Kores India Limited (2)

    filter

    01 1076-22-8 (5)

    filter

    01 China (1)

    02 India (4)

    ListList of Suppliers
    Contact SupplierContact Supplier
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag India
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      3-Methyl xanthine

      PDF Supplier PDF
      URL Supplier Web Content
      1076-22-8
      Linagliptin
      The Bakul Group of companies headquartered in Mumbai, India are engaged in the development and manuf...
      The Bakul Group of companies headquartered in Mumbai, India are engaged in the development and manufacture of high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, and Speciality Chemicals. Since our inception in 1975, we have grown to become world leaders in the area of xanthine chemistry. They specialize in manufacturing APIs such as Linagliptin, Pentoxifylline, Theobromine, Doxofylline, Caffeine, Pamabrom, and others.
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag India
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        3-MethyIxanthine

        PDF Supplier PDF
        URL Supplier Web Content
        1076-22-8
        Linagliptin
        Bulat Pharmaceutical is a fast growing pharmaceutical company, founded in the year 2017, Bulat Pharm...
        Bulat Pharmaceutical is a fast growing pharmaceutical company, founded in the year 2017, Bulat Pharmaceutical is engaged in the manufacturing and sales of high quality APIs and Intermediates.
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag India
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          3-Methylxanthine

          PDF Supplier PDF
          URL Supplier Web Content
          1076-22-8
          Linagliptin
          Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary ...
          Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content
          Contact Supplier
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag India
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            3-Methylxanthine

            PDF Supplier PDF
            URL Supplier Web Content
            1076-22-8
            Linagliptin
            The division was established in 1981 as a Specialty Chemicals Division with a focus to manufacture s...
            The division was established in 1981 as a Specialty Chemicals Division with a focus to manufacture specialty chemicals and pharmaceutical intermediates. In April 2006, the division has been renamed as ‘Pharmaceuticals & Chemicals Division’ to focus strongly on the manufacturing of active pharmaceutical ingredients and pharmaceutical intermediates. Located at Roha, the manufacturing site is about 140 km from the city of Mumbai and occupies an area of 40,000 sq.m. The division employs over 200 people and has the capacity to develop and execute a range of chemical processes. It also provides for innovative process design and scale-up.
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content
            Contact Supplier
              Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
              Post an Enquiry Post an Enquiry
              Flag India
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              3-Methylxanthine

              PDF Supplier PDF
              URL Supplier Web Content
              1076-22-8
              Propentofylline
              The division was established in 1981 as a Specialty Chemicals Division with a focus to manufacture s...
              The division was established in 1981 as a Specialty Chemicals Division with a focus to manufacture specialty chemicals and pharmaceutical intermediates. In April 2006, the division has been renamed as ‘Pharmaceuticals & Chemicals Division’ to focus strongly on the manufacturing of active pharmaceutical ingredients and pharmaceutical intermediates. Located at Roha, the manufacturing site is about 140 km from the city of Mumbai and occupies an area of 40,000 sq.m. The division employs over 200 people and has the capacity to develop and execute a range of chemical processes. It also provides for innovative process design and scale-up.
              ASK
              US
              PHARMACOMPASS
              Upload
              your Marketing & Sales content

              Looking for CAS 1076-22-8 ?

              Looking for CAS 1076-22-8 ? 5

              19

              Bakul Group, based in India, is a pharmaceutical company.

              One of their notable product 3-Methyl xanthine with CAS Number 1076-22-8.


              and End Use API Linagliptin

              18

              Bulat Pharmaceutical, based in India, is a pharmaceutical company.

              One of their notable product 3-MethyIxanthine with CAS Number 1076-22-8.


              and End Use API Linagliptin

              17

              Cangzhou Senary Chemical Science-tech Co., Ltd, based in China, is a pharmaceutical company.

              One of their notable product 3-Methylxanthine with CAS Number 1076-22-8.


              and End Use API Linagliptin

              16

              Kores India Limited, based in India, is a pharmaceutical company.

              One of their notable product 3-Methylxanthine with CAS Number 1076-22-8.


              and End Use API Linagliptin

              15

              Kores India Limited, based in India, is a pharmaceutical company.

              One of their notable product 3-Methylxanthine with CAS Number 1076-22-8.


              and End Use API Propentofylline

              Post Enquiry
              POST ENQUIRY